Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
Goodwill history
Currency unavailable · from the balance sheet
No Goodwill data reported for this period type.
Goodwill vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $145.93M USD | -3.2% | +3.0% | 8.8% | |
| Mar 2026 | $19.77M USD | -8.1% | -50.2% | 1.6% | |
| Mar 2026 | $13.48M USD | +0.0% | +0.0% | 4.6% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -3.2% | +0.0% | 4.6% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.